Lithuania · Seed startup

Who invested in VUGENE

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.1Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $1.1MMay 2025
Investors
2
See who backed them

The rounds

  1. May 2025
    Seed$1.1M

    Source recorded

Founders and team

From VUGENE's own website: 1 founder, 4 on the team.

Juozas GordevičiusFounder & CEO
  • Ramūnas MarkauskasCTO
  • Karolina GirdžiūnėHead of Finance & Operations
  • Karolina ŽukauskienėHead of Partnerships
  • Asta Balčiūnaitė GordevičienėCreative Director

Everyone who backed them

Superhero CapitalVC firm1round
Coinvest CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists VUGENE as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

SofigamaVC firmPer its own site

Quick answers about VUGENE

Who invested in VUGENE?

VUGENE's investors include Superhero Capital and Coinvest Capital.

How much has VUGENE raised?

VUGENE has raised $1.1M across 1 round since 2025.

When did VUGENE last raise?

VUGENE's most recent round was a Seed of $1.1M in May 2025.

What was VUGENE's biggest round?

Its most recent round, $1.1M in May 2025, is also its largest on record.

Who backed VUGENE first?

VUGENE's first round on record, in May 2025, was backed by Superhero Capital and Coinvest Capital.

What stage is VUGENE at?

VUGENE's latest named round is a Seed, in May 2025.

Where is VUGENE based?

VUGENE is based in Lithuania.

Companies like VUGENE

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.